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ABSTRACT
Purpose. This research describes and evaluates a liposuc-
tion surgery and multidisciplinary rehabilitation approach
for advanced lymphedema of the upper and lower extrem-
ties.
Methods. A prospective clinical study was conducted at
an Advanced Lymphedema Assessment Clinic (ALAC)
comprised of specialists in plastic surgery, rehabilitation,
imaging, oncology, and allied health, at Macquarie
University, Australia. Between May 2012 and 31 May
2014, a total of 104 patients attended the ALAC. Eligibility
criteria for liposuction included (i) unilateral, non-pitting,
International Society of Lymphology stage II/III lym-
phedema; (ii) limb volume difference greater than 25 %;
and (iii) previously ineffective conservative therapies. Of
55 eligible patients, 21 underwent liposuction (15 arm,
6 leg) and had at least 3 months postsurgical follow-up
(85.7 % cancer-related lymphedema). Liposuction was
performed under general anesthesia using a published
technique, and compression garments were applied
intraoperatively and advised to be worn continuously
thereafter. Limb volume differences, bioimpedance
spectroscopy (L-Dex), and symptom and functional mea-
surements (using the Patient-Specific Functional Scale)
were taken presurgery and 4 weeks postsurgery, and then
at 3, 6, 9, and 12 months postsurgery.
Results. Mean presurgical limb volume difference was
45.1 % (arm 44.2 %; leg 47.3 %). This difference reduced
to 3.8 % (arm 3.6 %; leg 4.3 %) by 6 months postsurgery,
a mean percentage volume reduction of 89.6 % (arm
90.2 %; leg 88.2 %) [p\ 0.001]. All patients had
improved symptoms and function. Bioimpedance spec-
troscopy showed reduced but ongoing extracellular fluid,
consistent with the underlying lymphatic pathology.
Conclusions. Liposuction is a safe and effective option for
carefully selected patients with advanced lymphedema.
Assessment, treatment, and follow-up by a multidisci-
plinary team is essential.
‘‘I was always alone and at my lowest point I wanted
to have my leg cut off. I remember going to my
General Practitioner and asking if that were possi-
ble’’, first leg liposuction patient (Fig. 1).
The negative impact of advanced lymphedema on the
physical and emotional health of cancer survivors cannot
be understated.1–9 Symptomatic management, rather than
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cure, is available for the large proportion of breast (21 %),
gynecologic (20 %), melanoma (16 %), and genitourinary
(10 %) cancer survivors (among others) who develop
lymphedema.10,11 Early lymphedema swelling can usually
be managed with decongestive lymphatic therapy (DLT):
lymphatic drainage massage, compression garments, exer-
cises, and skin care.2 However, until recently no further
treatments existed for advanced lymphedema resistant to
DLT. This report presents volume, bioimpedance, func-
tional, and emotional outcomes from the first Australian
clinic conducting liposuction for advanced lymphedema.
European teams first developed liposuction protocols for
advanced lymphedema,12–14 the rationale being that swel-
ling in advanced lymphedema is not only due solely to
lymphatic fluid but also to accumulating adipose tissue15,16
and sometimes fibrosis.17 Liposuction significantly reduces
excess limb volume12,17,18 for patients with advanced arm
or leg lymphedema,12,13,19,20 with ongoing reduction
maintained by continuous compression garment use.17,18,21
Furthermore, Swedish data suggest that liposuction reduces
episodes of cellulitis (often requiring hospitalization) from
an annual incidence of 40 % preoperatively to 10 %
postoperatively.22 The best outcomes post-liposuction are
achieved by patients who return frequently for monitoring
and garment renewal.14,18 However, this very need for
ongoing monitoring and expensive garments raises ques-
tions about whether liposuction will generalize out of the
universal healthcare contexts of Sweden and the UK to
countries such as Australia and the US where the cost of
lymphedema treatment is paid for by the individual.23
Furthermore, temperatures in Sweden and the UK are
comparatively low, making it more comfortable to wear
compression garments. Nevertheless, liposuction remains
the best contemporary surgical option to reduce swelling
for patients with advanced lymphedema because alterna-
tives, such as lymph node transfer (LNT) micro-
surgery,7,24–26 focus only on restoring lymphatic function
in the affected area. Although perhaps stopping the pro-
gression of advanced lymphedema, such techniques cannot
foreseeably reduce the fatty and fibrotic swelling already
present.
Two additional topics are not adequately addressed in
liposuction research. First, although liposuction substan-
tially improves function,3 studies disagree as to whether
liposuction improves emotional outcomes.3,13 Second, no
research has measured extracellular lymphatic fluid pre-
and post-liposuction using bioimpedance, an assessment
that will soon become standard-of-care for lymphedema.27
FIG. 1 First arm and leg liposuction patients, both right-side affected. Left panel pre-liposuction, middle panel 6 months post-liposuction, right
panel 12 months post-liposuction
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Therefore, in 2012, clinicians and researchers at Macquarie
University convened a multidisciplinary Advanced Lym-
phedema Assessment Clinic (ALAC) for privately funded
patients to carefully implement and evaluate liposuction for
lymphedema. This report presents volume, bioimpedance,
functional, and emotional outcomes after 2 years of this




Specialists in rehabilitation (HM), plastic surgery (TL,
QN), imaging (JM), oncology (JB), and allied health (LK,
AH-W) established ALAC in May 2012. TL was trained in
surgical technique by AM. TL, HM, and LK received
further instruction in technique and follow-up protocol
from HB in Sweden. HB also provided analysis tools to
ensure comparability with previous studies. At ALAC, a
rehabilitation specialist with expertise in lymphedema
(HM) took a patient’s medical history and assessed their
eligibility for surgery. A lymphedema-trained physiother-
apist (AH-W) measured limb volumes, took bioimpedance
spectroscopy (L-Dex), and assessed function. Eligible
patients discussed liposuction with the plastic surgeon
(TL). Preoperative magnetic resonance imaging (MRI)
assessed the location and extent of lymphatic fluid and fat
for surgical planning. If there was evidence of pitting
edema or substantial lymphatic fluid on MRI, patients
completed modified intensive DLT consisting of 1–2 weeks
of presurgery bandaging at a private rehabilitation hospital.
Patients returned to ALAC 2–6 weeks postsurgery and at 3,
6, 9, and 12 months to measure limb volume and order new
compression garments, and for reviews 6-monthly there-
after. If progress was good and new garments were not
required, 3- and/or 9-month assessment was omitted. MRI
was repeated at 6 months to reassess fluid and fat distri-
bution, and will be analyzed in future research to improve
muscle, fat, and fluid differentiation and measurement. All
cases were reviewed at monthly multidisciplinary team
meetings.
Patients’ motivation to wear, and their ability to pay for,
continuous garments was assessed. Patients without private
health insurance self-funded a 5-day hospital stay, theater
room hire, physiotherapy, and inpatient DLT.
Patients and Eligibility
Between May 2012 and May 2014, a total of 104
patients were assessed. Eligibility criteria for liposuction
were (i) unilateral nonpitting primary or secondary
advanced International Society of Lymphology (ISL) stage
II or III lymphedema;12,13 (ii) limb volume difference
greater than 25 % (calculated using the truncated-cone
method);12,13 and (iii) DLT provided no further volume
reductions. Patients were excluded if they had not under-
taken maximum DLT (n = 3), had active recurrent cancer
(n = 2), bilateral lymphedema (n = 5), frailty (n = 3), or
were reluctant to wear compression garments continuously
(n = 5).17,18,21
By May 2014, 21 of 55 eligible patients underwent
liposuction and were at least 3 months postsurgery. An
additional seven patients underwent surgery (four did not
consent to research and three had less than 3 months of
follow-up), eight were booked in, and 19 patients decided
against surgery or found the costs prohibitive (22 %).
Measures
Limb Volume Volume was calculated using 4-cm
truncated cone circumferential measurements.28 A mea-
suring board was used. Arms were measured seated, with
the arm in horizontal abduction, hand pronated, and
commencing at the ulnar styloid. Leg measurements were
taken in the supine position with legs slightly abducted,
commencing at the ankle between the lateral and medial
malleolus. Individual limb volume, difference between
limbs, and percentage difference were calculated, com-
paring the affected limb with the unaffected limb.28,29
Bioimpedance Spectroscopy (L-Dex) Measurements
were taken supine using the ImpediMed L-Dex machine
(ImpediMed, Carlsbad, CA, USA) that assesses extra-
cellular fluid in a unilateral limb using a low-voltage
electrical current. L-Dex readings are an impedance ratio
comparing the unaffected limb with the affected limb, with
the unaffected limb acting as a patient-specific internal
control.30 Skin was cleaned with alcohol swabs, and
electrodes placed according to the manufacturer’s recom-
mendations. Normal (no lymphedema) L-Dex readings
ranged between -10 and 10.31
Function/Emotions Functional impairment was assessed
using the Patient-Specific Functional Scale (PSFS).32 The
PSFS is reliable and valid across contexts,33 and sensitive
to change in breast cancer survivors,34 but not previously
validated for lymphedema. Patients listed three personally
important activities impaired by lymphedema (e.g. ‘brush-
ing my hair’), then rated the extent to which lymphedema
impaired each activity (‘0’, not able to perform, to ‘10’,
able). Therefore, although the specific activities nominated
by individuals differed substantially, impairment ratings
were standardized and thus comparable across activities,
patients, and time.32 Impairment ratings were summed for
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each patient, forming an individualized index of functional
impairment (range 0–30), with higher numbers indicating
less impairment. It was not appropriate to calculate internal
consistency (e.g. Cronbach’s a) because activities were
idiosyncratic across patients.
To complement the PSFS, patients also rated the impact
of lymphedema on six functional/emotional domains
drawn from previous research35,36 (see the Appendix):
pain, heaviness, extent of swelling, degree of self-con-
sciousness, anxiety, and negative emotions (‘0’, not at all,
to ‘10’, extremely so). Although the domains were corre-
lated (Cronbach’s a = 0.76), they were reported indi-
vidually because they reflect diverse content.
Surgical Technique and Compression Therapy
The surgical procedure was identical to that described in
Sweden.12,13,19,20 Liposuction was performed under general
anesthesia following limb exsanguination and tourniquet
application. Using specialized Helixed Tri Port III cannulas
(22 and 30 cm long, 4–5 mm wide) connected to a vacuum
pump, subcutaneous tissue was removed through multiple
small incisions along the limb. Presurgical limb volume
determined how much tissue to remove to equalize volume
relative to the unaffected limb. Compression garments were
applied to the affected limb immediately postsurgery prior
to tourniquet release—custom-made 30 mmHg JOBST
Elvarex for arms, or Ready Wraps (Solaris) for legs. From
1-week postsurgery, all leg patients wore JOBST Elvarex
custom-made compression garments 50–80 mmHg. Initial
postsurgical garments were measured using the circumfer-
ence of the unaffected limb; subsequent measurements were
obtained from the operated limb by a trained garment fitter.
Every order consisted of two garments, allowing one to be
worn while the other was washed. Throughout follow-up,
compression garments alone were used in areas where
liposuction was performed. However, DLT was used, where
indicated, in areas where liposuction was not performed
(hands or feet) or areas that cannot be adequately com-
pressed (shoulder or hip). These areas are not included in
limb volume measurements.28,29
Statistical Analysis
Volume, L-Dex, and function were compared with
paired samples t tests. As analysis entailed five pairwise
comparisons between succeeding timepoints (pre vs. post,
pre vs. 3-month, etc.), the Bonferroni correction was
applied, (i.e. p value was considered significant at 0.05/
5 = 0.0137). With 21 participants, we calculated 80 %
power at p = 0.01 to detect a d = 0.8 decrease in limb
volume and L-Dex. However, as fewer participants had
longer follow-up, less power was available at 12-month
follow-up. Hence, further clinically meaningful volume
reductions may not attain statistical significance. Statistical
tests were performed using SPSS version 21 for Windows
(IBM Corporation, Armonk, NY, USA). Data were col-
lected with patients’ consent and Macquarie University
Human Research Ethics Committee approval.
RESULTS
Table 1 details characteristics of 15 arm and 6 leg lipo-
suction patients. Cancer-related secondary lymphedema was
a more common reason for liposuction (85.7 %) than primary
(congenital) lymphedema (14.3 %), with breast cancer
treatment being the most common underling cause (66.7 %).
Patients with arm lymphedema were older (mean(arm) 57.8 -
years, range 25–69; mean(leg) 50.7, range 18–66) but had less
longstanding lymphedema (mean(arm) 9.1 years, range 2–29),
than patients with leg lymphedema (mean(leg) 15.5, range
3–42). All patients were female, reflecting the sex disparity in
lymphedema prevalence due to breast cancer.
Significant post-liposuction reduction in limb volume
was achieved for all patients (Table 2). Mean preoperative
limb difference was 45.1 % (range 23–83), decreasing
between 2 and 6 weeks postsurgery to 13.2 % (range -2 to
24), a significant 68.2 % reduction (range 35–104,
t(20) = 9.66; p\ 0.001). Limb volume difference further
reduced to 3.8 % by 6 months postsurgery, an 89.6 %
(range 38–149) reduction of presurgical volume (t(18) =
9.17; p\ 0.001). This near-complete reduction was
maintained to 12 months (n = 8), a 97.7 % reduction
(range 73–123, t(8) = 5.73; p\ 0.001).
Mean preoperative L-Dex was 42.9 (range 12–97) for all
patients. L-Dex increased 4 weeks postsurgery to 55.0
(range 32–73), reflecting the extracellular fluid associated
with postsurgical swelling (t(18) = -2.51; p = 0.02).
L-Dex was at presurgical values 6 months postsurgery
(mean 38.1, range 14–71, t(14) = 1.68; p = 0.12) and
reduced below presurgical values at 12 months (mean
27.1, range 13–45, t(7) = 3.38; p = 0.02). However,
L-Dex values remained elevated above the ‘normal’ range
(0 ± 10), likely indicating ongoing lymphatic pathology.
Although these comparisons were not statistically signifi-
cant (applying the Bonferroni correction), change from
timepoint to timepoint always exceeded the 10 points
considered clinically significant for L-Dex.
Functionally, all patients reported improvements on the
PSFS index of personally important activities (Table 3) by
6 months postsurgery (p\ 0.01). Improvements were also
evident in the standardized domains of pain, heaviness,
self-consciousness, levels of anxiety, perceived degree of
swelling, and emotional impact; such improvements were
statistically significant, with the exception of pain in the
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lower limb and anxiety about the upper limb. There have
been no surgical complications; one patient had poor
compression garment compliance.
DISCUSSION
‘‘The most emotional day was when I got my first
garment on – it was mind blowing to see my ankle
and calf so much the same size as my other leg.
Everything in my life has now changed – for the
better’’, first leg liposuction patient (Fig. 1).
A multidisciplinary team convened Australia’s first clinic
(ALAC) providing liposuction for lymphedema. European
protocols12,14,18,20,21 were applied within a unique multi-
disciplinary context, where the surgeon and occupational
therapist were joined by an oncologist and physiotherapist,
and led by a rehabilitation specialist. ALAC conducted
surgery on cancer-related lymphedema and primary (con-
genital) lymphedema. Liposuction was effective in this
privately-funded context, eliminating excess volume on
average and improving symptoms and function in the
affected limb. Patients maintained reductions to 12 months
by continuously wearing compression garments.
These results are comparable with international stan-
dards. Arm liposuction achieved mean volume reductions
of 90 % at 6 months and 97 % at 12 months postsurgery
compared with 103 and 111 % in Sweden,38 and 92 and
101 % (range 69–148) in the UK.13 Results 12 months
postsurgery were 116 % (range 75–233) in The Nether-
lands14 and 111 % (range 90–130) in the US.24 Leg surgery
achieved volume reductions of 88 % at 6 months and
101 % (one patient) at 12 months postsurgery compared
with 84 % at 3 months and 105 % at 12 months post-
surgery in Sweden,20 and 86 % (range 81–97) 12 months
postsurgery in the US.24
Previous liposuction research demonstrated improved
quality of life3 and overall wellbeing,13 but disagreed about
improvements in emotional wellbeing.3,13 In ALAC,
patients reported substantial and statistically significant
reduction in lymphedema impact on important activities,
improved limb function, and reduced lymphedema-specific
emotional distress. Thus, liposuction has substantial func-
tional and psychological benefit.
These results are preliminary owing to the small number
of patients. Nevertheless, they are clinically and statistically
significant despite the expense associated with self-funding
compression garments and the discomfort of wearing gar-
ments continuously in Australia’s hot climate. Liposuction
addresses physical swelling but not the underlying lym-
phatic dysfunction; therefore, patients must maintain
garment use to continue to benefit from the surgery. How-
ever, we have anecdotes that some patients are wearing
compression intermittently yet continuing to maintain
reduction. ALAC is planning to explore whether less bur-
densome garment requirements are possible through a
randomized controlled trial of durations and levels of com-
pression after liposuction for upper limb lymphedema.
All patients experienced benefit and there were no
adverse events. This is consistent with lymphoscintigraphy
studies demonstrating that liposuction is not associated
with further damage to lymphatic transport in arms with
lymphedema,39 and with a cadaveric study which demon-
strated that longitudinal liposuction does not damage the
epifascial lymph vessels.40 These results are early indica-
tions that liposuction is safe and will not additionally
compromise lymphatic drainage, either in primary or sec-
ondary lymphedema.
Although the treatment protocol at ALAC was similar to
others,12,14,18,20,21 the clinic composition was expanded. In
addition to a surgeon and occupational therapist/physio-
therapist, the lead clinician was a rehabilitative specialist,
i.e. liposuction was seen as the first step in ongoing
TABLE 1 Participant characteristics
Upper Limb Lower Limb Total (%)
n n
Sex
Female 15 6 21 100
Age (years)
\50 2 1 3 14.3
C50 13 5 18 85.7
Mean (SD) 57.8 (12.2) 50.7 (16.9)
Range 25–69 18–66
BMI (kg/m2)
Mean (SD) 28.3 (4.1) 29.69 (2.7)
Low to normal (\25) 3 0 3 14.3
Overweight (25–30) 7 4 11 52.4
Obese ([30) 5 2 7 33.3
Cancer diagnosis
Breast 14 0 14 66.7
Gynecological 0 4 4 19.0
Non-cancer 1 2 3 14.3
Nodal surgery
Nil 1 5 6 28.6
Sentinel node biopsy 1 0 1 4.8
Nodal dissection 13 1 14 66.7
Radiotherapy
Yes 11 1 12 57.1
No 4 5 9 42.9
Chemotherapy
Yes 11 2 13 61.9
No 4 4 8 38.1
SD standard deviation, BMI body mass index
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TABLE 2 Excess volume and L-Dex value pre- and postoperatively
Preoperative 6 months 12 months 18 months
Upper limb (n) 15 12 7 1
L-Dex [mean (range)] 41.2 (18–75) 35.3 (14–49) 25.1 (13–45) 27
Significance – p = 0.068 p = 0.018 –
Mean excess volume [ml (range)] 1139.5 (645–1755) 67.9 (-697 to 422) 18.7 (-244 to 218) -339a
Mean excess volume [% (range)] 44.2 (27–67) 3.6 (-21 to 21) 1.3 (-5 to 8) -11a
Significance – p\ 0.001 p = 0.001 –
Lower limb (n) 6 5 1 0
L-Dex [mean (range)] 46.9 (12–97) 49.3 (33–71) 39.0 –
Significance – p = 0.746 – –
Mean excess volume [ml (range)] 4058 (2068–8294) 400 (-112 to 867) -103 –
Mean excess volume [% (range)] 47.3 (23–83) 4.3 (-1 to 11) -1.0 –
Significance – p = 0.018 – –
Significance assessed using paired samples t tests compared with preoperative value
a This patient gained weight overall but increased in fat volume in the unaffected arm only, i.e. the affected arm is now smaller than the
unaffected arm
TABLE 3 Functional and emotional impact of lymphedema before and after liposuction
Preoperative 6 months Effect at 6-month follow-up
Mean (range) Mean (range) N t p value
PSFS functional impairmenta
Upper limb 11.1 (4–21) 22.1 (9–30) 7 3.86 0.008
Lower limb 7.4 (4–9) 28.0 (27–29) 5 23.6 \0.001
Painb
Upper limb 3.9 (0–8) 0.8 (0–3) 9 3.60 0.007
Lower limb 3.7 (0–8) 0.2 (0–1) 5 2.50 0.07
Heavinessb
Upper limb 6.7 (3–10) 0.3 (0–2) 9 9.71 \0.001
Lower limb 8.2 (6–10) 0.4 (0–2) 5 7.65 0.002
Self-consciousnessb
Upper limb 6.9 (2–10) 0.6 (0–3) 9 5.94 \0.001
Lower limb 8.2 (4–10) 0 5 24.59 \0.001
Anxiousb
Upper limb 5.1 (0–10) 0.2 (0–2) 9 3.31 0.11
Lower limb 7.2 (5–10) 0 5 9.36 \0.001
Swollenb
Upper limb 6.9 (2–10) 1.8 (0–4) 9 5.49 \0.001
Lower limb 9.0 (8–10) 1.6 (0–2) 5 9.89 \0.001
Impact on emotionsb
Upper limb 6.0 (0–10) 1.0 (0–4) 9 4.07 0.004
Lower limb 7.8 (2–10) 0.6 (0–3) 5 12.37 \0.001
Significance assessed using paired samples t tests compared with preoperative value
PSFS Patient-Specific Functional Scale32
a Scores ranged from ‘0’ (not able to perform three activities at all) to ‘30’ (able to perform three activities perfectly)
b Scores ranged from ‘0’ (not at all) to ‘10’ (extremely so)
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nonsurgical management, including compression garment
use requiring regular reordering.13,21,24 In addition, an
oncologist was present to balance cosmesis, function, and
quality of life against prognosis, if necessary. ALAC holds
the conviction that the highest standard of care is achieved
within this multidisciplinary environment.
Future research should determine selection criteria and
sequencing for other surgical procedures. Our clinic is
evaluating LNT7,41 for patients with ISL stage I or II lym-
phedema where pitting edema rather than fat is the clinical
presentation. LNT? delayed autologous breast reconstruc-
tion is another potential approach for patients undergoing a
mastectomy.24–26 Furthermore, surgeries might be com-
bined, such as liposuction to remove fatty lymphedema
followed by LNT± autologous breast reconstruction to
eliminate the need for compression garments. The appro-
priate surgical approach can be defined using lymphedema
clinical characteristics;24 ALAC holds the additional belief
that patient factors such as motivation and the ability to pay
for compression garments must be assessed.
CONCLUSIONS
With continued compression garment use, ALAC
expects patients to maintain limb reductions as reported in
5- to 15-year follow-up in Europe.13,20,38 Only one patient
has failed to maintain compliance for garment use, for
unknown reasons. However, these Australian patients were
carefully selected with regard to their long-term ability to
pay for garments. Costs prevented 12 eligible patients from
undergoing surgery. Considering the significant functional
gains observed in this and other studies,3,13,24 and reduced
hospitalizations due to infection,8,9,22 governments and
insurance companies should consider the economic value
of funding liposuction for advanced lymphedema.
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